Related Experiment Video

Updated: Aug 13, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

The vascular biology of atherosclerosis

Jorge Plutzky1

  • 1Vascular Disease Prevention Program, Cardiovascular Division, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

The American Journal of Medicine
|December 18, 2003
PubMed

Insights

Thiazolidinediones (TZDs) show promise in combating atherosclerosis, particularly in patients with type 2 diabetes. These drugs may reduce inflammation and improve cholesterol in preclinical models, suggesting a potential cardiovascular benefit.

Area of Science:

  • Cardiology
  • Endocrinology
  • Immunology

Background:

  • Atherosclerosis is a significant cardiovascular issue, especially in patients with insulin resistance and type 2 diabetes mellitus.
  • Atherosclerosis is an inflammatory condition involving complex cellular and mediator interactions.
  • Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands, like thiazolidinediones (TZDs), are being investigated for their anti-atherosclerotic potential.

Purpose of the Study:

  • To explore the potential mechanisms by which TZDs may ameliorate atherosclerosis.
  • To evaluate the effects of TZDs on inflammatory pathways and cholesterol metabolism relevant to atherosclerosis.
  • To assess the combined impact of TZDs on metabolic parameters and atherosclerotic progression.

Main Methods:

  • In vitro studies examining cellular responses to TZDs.
  • In vivo studies using animal models of atherosclerosis treated with TZDs.
  • Analysis of TZD effects on cholesterol efflux, cytokine expression, and chemokine levels.

Main Results:

  • In vitro and animal models suggest TZDs can increase macrophage cholesterol efflux.
  • TZD treatment in mouse models showed decreased atherosclerosis, linked to reduced cytokine and chemokine levels.
  • TZDs may improve atherosclerosis by directly impacting inflammatory processes and indirectly via enhanced insulin sensitivity.

Conclusions:

  • TZDs demonstrate potential therapeutic benefits against atherosclerosis through anti-inflammatory and cholesterol-modulating effects.
  • The combined metabolic and direct vascular actions of TZDs warrant further investigation in clinical settings.
  • Ongoing clinical trials are crucial for determining the cardiovascular outcomes of TZD therapy.

More Related Videos

Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis09:55

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Published on: October 25, 2024

Related Concept Videos

Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...